BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $11.43 billion as of July 20, 2026. Its market cap has increased by 3.99% in one year.

• Market Cap: 11.43B
• Enterprise Value: 10.64B
• 1-Year Change: 3.99%
• Ranking: #888
• Category: Large-Cap
• Stock Price: $59.11

Market Cap Chart

Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $11.43B, an increase of 2,476.69%. That is a compound annual growth rate of 12.79%.

Market Cap History

Date	Market Cap	% Change
Jul 20, 2026	11.43B	0.07%
Dec 31, 2025	11.42B	-8.86%
Dec 31, 2024	12.53B	-31.03%
Dec 29, 2023	18.16B	-5.57%
Dec 30, 2022	19.23B	18.58%
Dec 31, 2021	16.22B	1.90%
Dec 31, 2020	15.92B	4.81%
Dec 31, 2019	15.19B	0.17%
Dec 31, 2018	15.16B	-3.18%
Dec 29, 2017	15.66B	9.92%
Dec 30, 2016	14.25B	-15.66%
Dec 31, 2015	16.89B	26.72%
Dec 31, 2014	13.33B	33.25%
Dec 31, 2013	10.00B	64.58%
Dec 31, 2012	6.08B	54.81%
Dec 30, 2011	3.93B	42.26%
Dec 31, 2010	2.76B	45.68%
Dec 31, 2009	1.89B	6.63%
Dec 31, 2008	1.78B	-48.15%
Dec 31, 2007	3.43B	128.90%
Dec 29, 2006	1.50B	87.98%
Dec 30, 2005	796.50M	93.28%
Dec 31, 2004	412.10M	-16.92%
Dec 31, 2003	496.00M	31.08%
Dec 31, 2002	378.40M	-36.33%

View and export this data all the way back to 1999. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 20, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 20, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Madrigal Pharmaceuticals	12.76B
Axsome Therapeutics	11.84B
ABIVAX Société Anonyme	11.76B
Bio-Techne	11.24B
Cytokinetics	10.89B
Summit Therapeutics	10.72B
Arrowhead Pharmaceuticals	10.47B
Krystal Biotech	10.46B